Difference between revisions of "Cancer United"
Jump to navigation
Jump to search
m (SW: add category) |
m (Text replacement - "{{#badges:" to "{{Show badges|") |
||
| (6 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | {{ | + | {{Show badges| Front groups}} |
| − | |||
| − | In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by | + | '''Cancer United''' is a [[pharmaceutical industry]] [[front group]] established by the [[Weber Shandwick]] [[public relations firm]] and funded entirely by [[Roche]]. |
| + | |||
| + | In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by Roche, the maker of Herceptin and Avastin. A senior company executive sits on the board. The company's PR firm, Weber Shandwick has been heavily promoting the group to clinicians and journalists. The principal study on which the group is based was also funded by Roche Laboratories and has been hotly contested. <ref>Sarah Boseley, "[http://business.guardian.co.uk/story/0,,1924748,00.html Concern over cancer group's link to drug firm]", ''Guardian (UK), October 18, 2006.</ref> | ||
==Contact Details== | ==Contact Details== | ||
| Line 27: | Line 28: | ||
=== External articles === | === External articles === | ||
| − | |||
*Faisal Islam , "[http://www.channel4.com/news/special-reports/special-reports-storypage.jsp?id=3657 Roche faces cancer probe]", ''Channel Four'', October 19, 2006. | *Faisal Islam , "[http://www.channel4.com/news/special-reports/special-reports-storypage.jsp?id=3657 Roche faces cancer probe]", ''Channel Four'', October 19, 2006. | ||
*Sarah Boseley and David Gow, "[http://politics.guardian.co.uk/eu/story/0,,1926952,00.html Support for cancer group naive, says MP]", Guardian (UK), October 20, 2006. | *Sarah Boseley and David Gow, "[http://politics.guardian.co.uk/eu/story/0,,1926952,00.html Support for cancer group naive, says MP]", Guardian (UK), October 20, 2006. | ||
Latest revision as of 15:47, 25 December 2019
 |
This article is part of the Center for Media & Democracy's spotlight on front groups and corporate spin. |
Cancer United is a pharmaceutical industry front group established by the Weber Shandwick public relations firm and funded entirely by Roche.
In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by Roche, the maker of Herceptin and Avastin. A senior company executive sits on the board. The company's PR firm, Weber Shandwick has been heavily promoting the group to clinicians and journalists. The principal study on which the group is based was also funded by Roche Laboratories and has been hotly contested. [1]
Contents
Contact Details
Web: http://www.cancerunited.org/
Articles & sources
SourceWatch Resources
- Health Care
- Midwest Heart Foundation
- Doctor Run Charities
- Patient Groups/Australia
- Patient Groups/Europe
- Patient Groups/International
- Patient Groups/UK
- Patient Groups/US
- Patient Groups/Canada
- Roche
- Pharmaceutical industry
- War on Cancer
References
- ↑ Sarah Boseley, "Concern over cancer group's link to drug firm", Guardian (UK), October 18, 2006.
External articles
- Faisal Islam , "Roche faces cancer probe", Channel Four, October 19, 2006.
- Sarah Boseley and David Gow, "Support for cancer group naive, says MP", Guardian (UK), October 20, 2006.
- Sarah Boseley, "Hiding behind the patients: Of course drug companies have a voice in the debate about cancer care. But they should be more open about it", Comment IS Free (Guardian blog), October 20, 2006.
- David Miller 'This campaign brought to you by...' Spinwatch, 29 October 2006.
